Mid-cap stocks can offer an interesting balance between established businesses and higher growth potential. But simply choosing a mid-cap company because it has delivered strong returns in the past can be risky. The focus should be on business quality, competitive advantages, cash generation, balance-sheet strength and whether the current valuation can be justified by future earnings growth. These five stocks stand out across healthcare, IT, jewellery, auto components and energy storage.
1. Mankind Pharma
- Revenue has nearly doubled over five years, from around ₹6,385 crore to ₹12,744 crore. Operating margins have remained broadly stable at 24–27% despite strong growth.
- Operating cash flow has increased from around ₹1,070 crore to over ₹2,400 crore. The Bharat Serums & Vaccines acquisition expands its presence in women’s healthcare, fertility and specialty therapies.
- The company is gradually shifting toward higher-value healthcare segments.The key risk is the execution and integration of the Bharat Serums acquisition.
2. Coforge
- Revenue increased from around ₹5,700 crore in FY20 to approximately ₹11,700 crore by FY25. FY25 revenue growth was around 29%, while operating margins remained broadly in the 18–20% range.
- Its $1.75 billion order book provides strong visibility for future revenue.Operating cash flow has increased from around ₹560 crore to more than ₹1,100 crore.
- Strong execution in niche verticals and large deal wins are key strengths.AI provides an additional growth opportunity, although the investment thesis is not dependent entirely on AI.The major risk is a global slowdown or delay in enterprise IT spending.
3. Senco Gold
- Provides exposure to India’s long-term shift toward organised jewellery retail.Revenue has increased from around ₹2,675 crore to approximately ₹8,430 crore.
- The source highlights a valuation of around 12x P/E, which appears relatively reasonable compared with the broader organised jewellery space.The company continues to expand its retail network.
- Promoter holding of around 64% provides significant promoter ownership.Its long operating history and established brand provide an important trust advantage in jewellery retail.The key risks are working-capital management, gold-price volatility and execution of store expansion.
4. Endurance Technologies
- Revenue increased from around ₹6,578 crore to approximately ₹14,596 crore.
- Operating margins have remained broadly within the 12–16% range despite the cyclical nature of the auto-component industry.Operating cash flow increased from around ₹740 crore to more than ₹1,530 crore.
- The company has a strong balance sheet, with debt-to-equity of approximately 0.16.Supplies critical components including braking systems, suspension components, alloy wheels and aluminium castings.
- Its diversified customer base means the business isn’t dependent on a single automobile brand.The investment thesis is broader than EVs, as quality components should remain relevant across petrol, hybrid and electric vehicles.Key risks include an auto-sector slowdown, raw-material inflation and excessive dependence on major OEMs.
5. Amara Raja Energy & Mobility
- Provides exposure to the expanding energy-storage opportunity, beyond traditional automotive batteries.Revenue has grown significantly, while operating cash flow reached around ₹1,350 crore in FY25 according to the source.
- Its debt-to-equity ratio of approximately 0.03 indicates a strong balance sheet. The company is investing in lithium-ion cell manufacturing and advanced energy-storage solutions.Its existing battery business provides cash generation that can support investments in newer technologies.
- Successful execution could allow the company to participate in a broader energy-storage ecosystem rather than remaining dependent only on automotive batteries.The major risks are intense competition, rapidly evolving battery technology and execution of the lithium-ion expansion.
